I
321.36
0.36 (0.11%)
| 前收盘价格 | 321.00 |
| 收盘价格 | 319.00 |
| 成交量 | 615,511 |
| 平均成交量 (3个月) | 911,733 |
| 市值 | 22,615,674,880 |
| 市盈率 (P/E TTM) | 57.80 |
| 预期市盈率 (P/E Forward) | 70.92 |
| 价格/销量 (P/S) | 9.49 |
| 股市价格/股市净资产 (P/B) | 14.91 |
| 52周波幅 | |
| 利润日期 | 6 Aug 2025 - 11 Aug 2025 |
| 营业毛利率 | 18.29% |
| 营业利益率 (TTM) | 15.61% |
| 稀释每股收益 (EPS TTM) | 5.54 |
| 季度收入增长率 (YOY) | 28.80% |
| 季度盈利增长率 (YOY) | -31.30% |
| 总债务/股东权益 (D/E MRQ) | 131.40% |
| 流动比率 (MRQ) | 4.47 |
| 营业现金流 (OCF TTM) | 406.50 M |
| 杠杆自由现金流 (LFCF TTM) | 84.25 M |
| 资产报酬率 (ROA TTM) | 6.94% |
| 股东权益报酬率 (ROE TTM) | 37.92% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 看跌 | 看跌 |
| Medical Devices (全球的) | 看跌 | 看跌 | |
| 股票 | Insulet Corporation | 看跌 | 看涨 |
AIStockmoo 评分
0.6
| 分析师共识 | 2.0 |
| 内部交易活动 | 0.0 |
| 价格波动 | -0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.60 |
|
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Mid Growth |
| 内部持股比例 | 0.29% |
| 机构持股比例 | 102.56% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 380.00 (Goldman Sachs, 18.25%) | 购买 |
| 380.00 (Citigroup, 18.25%) | 购买 | |
| 中 | 356.50 (10.94%) | |
| 低 | 300.00 (Barclays, -6.65%) | 保留 |
| 平均值 | 354.75 (10.39%) | |
| 总计 | 7 购买, 1 保留 | |
| 平均价格@调整类型 | 313.66 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Barclays | 21 Aug 2025 | 300.00 (-6.65%) | 保留 | 308.68 |
| Canaccord Genuity | 08 Aug 2025 | 353.00 (9.85%) | 购买 | 307.10 |
| RBC Capital | 08 Aug 2025 | 350.00 (8.91%) | 购买 | 307.10 |
| Wells Fargo | 08 Aug 2025 | 350.00 (8.91%) | 购买 | 307.10 |
| Truist Securities | 16 Jun 2025 | 365.00 (13.58%) | 购买 | 306.59 |
| Goldman Sachs | 30 May 2025 | 380.00 (18.25%) | 购买 | 325.03 |
| Raymond James | 27 May 2025 | 360.00 (12.02%) | 购买 | 326.64 |
| Citigroup | 22 May 2025 | 380.00 (18.25%) | 购买 | 321.00 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| SINGH PREM | - | 303.55 | -1,343 | -407,668 |
| 累积净数量 | -1,343 | |||
| 累积净值 ($) | -407,668 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 303.55 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| SINGH PREM | 职员 | 07 Aug 2025 | 自动卖出 (-) | 1,343 | 303.55 | 407,668 |
| SINGH PREM | 职员 | 07 Aug 2025 | 执行期权 | 1,343 | - | - |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合